Vaccine effectiveness against the Omicron variant is "significantly lower" than with the Delta variant but a booster dose raises protection against mild cases, a new study has found.
Research released on Friday by the UK Health Security Agency found that a full two-dose vaccination course was less effective against symptomatic disease with Omicron than with the original strain of COVID-19 or the Delta variant.
It found however that "moderate to high vaccine effectiveness against mild infection of 70-75% was seen in the early period after a booster dose."
Omicron was designated a variant of concern by the World Heath Organisation (WHO) in late November over concerns its high number mutations could make it more transmissible and more resistant
Read more on euronews.com